WHO. World Malaria Report 2021. Geneva, World Health Organization, 2021.
MoH. Informasi Malaria Indonesia. Jakarta; 2021.
malERA Refresh Consultative Panel on Insecticide and Drug Resistance. malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication. PLoS Med. 2017;14:e1002450.
WHO. Zero malaria starts with me”: history of malaria elimination in Indonesia helps to shape a malaria-free future. Geneva, World Health Organization, 2020.
Elyazar IR, Hay SI, Baird JK. Malaria distribution, prevalence, drug resistance and control in Indonesia. Adv Parasitol. 2011;74:41–175.
Article
PubMed
PubMed Central
Google Scholar
MoH. High Malaria Endemic Areas. Jakarta; 2021.
Ministry of Health. Buku Saku Tatalaksana Kasus Malaria. Jakarta: Ministry of Health of the Republic of Indonesia; 2020.
Google Scholar
Clyde DF, McCarthy VC, Miller RM, Hornick RB. Chloroquine-resistant falciparum malaria from Irian Jaya (Indonesian New Guinea). J Trop Med Hyg. 1976;79:38–41.
PubMed
CAS
Google Scholar
Syafruddin D, Krisin, Asih P, Sekartuti, Dewi RM, Coutrier F, et al. Seasonal prevalence of malaria in West Sumba district, Indonesia. Malar J. 2009;8:8.
Pribadi W. In vitro sensitivity of Plasmodium falciparum to chloroquine and other antimalarials in east Timor and east Kalimantan, Indonesia. Southeast Asian J Trop. 1992;23:143–8.
Google Scholar
Fryauff DJ, Baird JK, Candradikusuma D, Masbar S, Sutamihardja MA, Leksana B, et al. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia. Am J Trop Med Hyg. 1997;56:241–4.
Maguire J, Susanti A, Krisin, Sismadi P, Fryauff D, Baird J. e T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia. Ann Trop Med Parasitol. 2001;95:559–72.
Nagesha HS, Din-Syafruddin, Casey GJ, et al. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. Trans R Soc Trop Med Hyg. 2001;95:43–9.
Baird JK, Wiady I, Sutanihardja A, Suradi, Purnomo, Basri H, et al. Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. Am J Trop Med Hyg. 2002;66:659–60.
Syafruddin D, Asih PB, Aggarwal SL, Shankar AH. Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Purworejo district, Central Java Province. Indonesia Am J Trop Med Hyg. 2003;69:614–20.
Article
PubMed
CAS
Google Scholar
Ministry of Health, Republic of Indonesia. Keputusan menteri kesehatan republik indonesia nomor hk.01.07/menkes/556/2019 tentang pedoman nasional pelayanan kedokteran tata laksana malaria. 2019. https://yankes.kemkes.go.id/unduhan/fileunduhan_1610416186_13796.pdf
Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982–91.
Article
PubMed
PubMed Central
Google Scholar
Djimdé A, Doumbo OK, Steketee RW, Plowe CV. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet. 2001;358:890–1.
Article
PubMed
Google Scholar
Sidhu AB, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002;298:210–3.
Article
PubMed
CAS
PubMed Central
Google Scholar
Adam R, Mukhtar MM, Abubakar UF, Damudi HA, Muhammad A, Ibrahim SS. Polymorphism analysis of pfmdr1 and pfcrt from Plasmodium falciparum isolates in Northwestern Nigeria revealed the major markers associated with antimalarial resistance. Diseases. 2021;9:6.
Article
PubMed
CAS
PubMed Central
Google Scholar
Happi CT, Gbotosho GO, Folarin OA, Bolaji ON, Sowunmi A, Kyle DE, et al. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg. 2006;75:155–61.
Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, et al. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin. Antimicrob Agents Chemother. 2014;58:7032–40.
Article
PubMed
PubMed Central
Google Scholar
Ebisawa I, Fukuyama T. Chloroquine resistance of Plasmodium falciparum in West Irian and East Kalimantan. Ann Trop Med Parasitol. 1975;69:275–82.
Article
PubMed
CAS
Google Scholar
Huaman MC, Yoshinaga K, Suryanatha A, Suarsana N, Kanbara H. Short report: polymorphisms in the chloroquine resistance transporter gene in Plasmodium falciparum isolates from Lombok. Indonesia Am J Trop Med Hyg. 2004;71:40–2.
Article
PubMed
CAS
Google Scholar
Saleh I, Handayani D, Anwar C. Polymorphisms in the pfcrt and pfmdr1 genes in Plasmodium falciparum isolates from South Sumatera. Indonesia Med J Indones. 2014;23:3–8.
Article
Google Scholar
Hutapea AM. Treatment of falciparum malaria with combined sulfadoxine and pyrimethamine in Jayapura. Indonesia Bul Penelit Kesehat. 1979;7:9–13.
Google Scholar
Tjitra E, Gunawan S, Laihad F, Marwoto H, Sulaksono S. Evaluation of antimalarial drugs in Indonesia 1981–1995. Bul Penelit Kesehat. 1997;25:27–58.
Google Scholar
WHO Scientific Group on the Chemotherapy of Malaria & World Health Organization. Practical chemotherapy of malaria: report of a WHO scientific group. 1990. World Health Organization. https://apps.who.int/iris/handle/10665/39778
Basuki S, Fitriah, Riyanto S, Budiono, Dachlan YP, Uemura H. Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia. Malar J. 2014;13:135.
Syafruddin D, Asih PB, Wahid I, Dewi RM, Tuti S, Laowo I, et al. Malaria prevalence in Nias District, North Sumatra Province. Indonesia Malar J. 2007;6:116.
Article
PubMed
Google Scholar
Asih PB, Rogers WO, Susanti AI, Rahmat A, Rozi IE, Kusumaningtyas MA, et al. Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba. Indonesia Malar J. 2009;8:222.
Article
PubMed
Google Scholar
Fitriah F, Sulistyawati S, Riyanto S, Budiono, Basuki S, Dachlan YP, et al. Polymorphism of Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes among pregnant women with falciparum malaria in Banjar District, South Kalimantan Province, Indonesia. J Trop Life Sci. 2012;2:92–8.
Syafruddin D, Asih PB, Siregar JE, Tjitra E. Molecular basis of antimalarial drug resistance in Indonesia. Adv Exp Med Biol. 2003;531:103–15.
Article
PubMed
CAS
Google Scholar
Mukh S, Darlina, Siti N. Deteksi spesies parasit malaria berbasis 18s rrna dan uji resistensinya terhadap obat untuk gen dhps sebagai pendukung pengembangan vaksin malaria iradiasi. Prosiding Seminar PSTA dan UNS: PSTA BATAN 2016:7–13. http://repo-nkm.batan.go.id/2752/1/DETEKSI%20SPESIES.pdf
Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, et al. Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes. Malar J. 2015;14:272.
Article
PubMed
PubMed Central
Google Scholar
Hastings MD, Maguire JD, Bangs MJ, Zimmerman PA, Reeder JC, Baird JK, et al. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. Antimicrob Agents Chemother. 2005;49:733–40.
Article
PubMed
CAS
PubMed Central
Google Scholar
Basuki S, Fitriah, Risamasu PM, Kasmijati, Ariami P, Riyanto S, et al. Origins and spread of novel genetic variants of sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia. Malar J. 2018;17:475.
Rumans LW, Dennis DT, Atmosoedjono S. Fansidar resistant falciparum malaria in Indonesia. Lancet. 1979;2:580–1.
Article
PubMed
CAS
Google Scholar
Hoffman SL, Campbell J, Rustama D, Dimpudus AJ, Surumpaet B, Rusch J, et al. Pyrimethamine-sulfadoxine still effective against Plasmodium falciparum in Jayapura, Irian Jaya: RI-type resistance in 2 of 18 patients. Trans R Soc Trop Med Hyg. 1987;81:276–7.
Article
PubMed
CAS
Google Scholar
Maguire JD, Lacy MD, Sururi, Sismadi P, Krisin, Wiady I, et al. Chloroquine or sulfadoxine–pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. Ann Trop Med Parasitol. 2002;96:655–68.
Hoffman SL, Dimpudus AJ, Campbell JR, Marwoto HA, Sukri N, Rustama D, et al. RII and RIII type resistance of Plasmodium falciparum to a combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia. Lancet. 1985;2:1039–40.
Article
PubMed
CAS
Google Scholar
Baird JK, Basri H, Jones TR, Purnomo, Bangs MJ, Ritonga A. Resistance to antimalarials by Plasmodium falciparum in Arso Pir, Irian Jaya, Indonesia. Am J Trop Med Hyg. 2002;44:640–4.
Fryauff DJ, Leksana B, Masbar S, Wiady I, Sismadi P, Susanti AI, et al. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia. Ann Trop Med Parasitol. 2002;96:447–62.
Article
PubMed
CAS
Google Scholar
WHO. World health statistics 2018: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization, 2018. https://apps.who.int/iris/handle/10665/272596.
WHO. Artemisinin resistance and artemisinin-based combination therapy efficacy: a status report. Geneva: World Health Organization, 2018. https://apps.who.int/iris/handle/10665/274362.
Ministry of Health, Republic of Indonesia. Epidemiologi Malaria di Indonesia. 2011. https://pusdatin.kemkes.go.id/resources/download/pusdatin/buletin/buletin-malaria.pdf
WHO. Guidelines for malaria. Geneva: World Health Organization, 2021. https://www.who.int/publications/i/item/guidelines-for-malaria
Djatmiko W. Uji efikasi terapi kombinasi artesunate + amodiaquine pada malaria falciparum tanpa komplikasi di kabupaten banjarnegara propinsi jawa tengah [Masters thesis]. Semarang: Universitas Diponegoro; 2005. http://eprints.undip.ac.id/12561/
Hasugian AR, Purba HL, Kenangalem E, Wuwung RM, Ebsworth EP, Maristela R, et al. Dihydroartemisinin–piperaquine versus artesunate–amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis. 2007;44:1067–74.
Article
PubMed
CAS
Google Scholar
Faranita. Pedoman Tatalaksana Kasus Malaria di Indonesia. 2005
Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ. Antimalarial drug resistance: literature review and activities and findings of the ICEMR Network. Am J Trop Med Hyg. 2015;93:57–68.
Article
PubMed
CAS
PubMed Central
Google Scholar
Sim I-K, Davis TME, Ilett KF. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob Agents Chemother. 2005;49:2407–11.
Article
PubMed
CAS
PubMed Central
Google Scholar
Dhingra SK, Gabryszewski SJ, Small-Saunders JL, Yeo T, Henrich PP, Nok S, et al. Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness. mBio. 2019;10:e02731–18.
Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis. 2017;17:164–73.
Article
PubMed
CAS
Google Scholar
Witkowski B, Duru V, Khim N, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study [published correction appears in Lancet Infect Dis. 2018;18:829]. Lancet Infect Dis. 2017;17:174–83.
Article
PubMed
CAS
PubMed Central
Google Scholar
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria [published correction appears in N Engl J Med. 2009 Oct 22;361:1714]. N Engl J Med. 2009;361:455–67.
Article
PubMed
CAS
PubMed Central
Google Scholar
Dondorp AM, Fairhurst RM, Slutsker L, Macarthur JR, Breman JG, Guerin PJ, et al. The threat of artemisinin-resistant malaria. N Engl J Med. 2011;365:1073–5.
Article
PubMed
CAS
PubMed Central
Google Scholar
Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453–64.
Article
PubMed
PubMed Central
Google Scholar
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5.
Article
PubMed
Google Scholar
Fairhurst RM, Dondorp AM. Artemisinin-resistant Plasmodium falciparum malaria. Microbiol Spectr. 2016;4. https://doi.org/10.1128/microbiolspec.EI10-0013-2016.
Asih PBS, Rozi IE, Dewayanti FK, Wangsamuda S, Zulfah S, Robaha M, et al. Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Northern Papua and Jambi, Indonesia. medRxiv. 2020.
Dalmat R, Naughton B, Kwan-Gett TS, Slyker J, Stuckey EM. Use cases for genetic epidemiology in malaria elimination. Malar J. 2019;18:163.
Article
PubMed
PubMed Central
Google Scholar
Daniels RF, Rice BL, Daniels NM, Volkman SK, Hartl DL. The utility of genomic data for Plasmodium vivax population surveillance. Pathog Glob Health. 2015;109:153–61.
Article
PubMed
PubMed Central
Google Scholar
Price RN, Hasugian AR, Ratcliff A, Siswantoro H, Purba HL, Kenangalem E, et al. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin–piperaquine for drug-resistant malaria. Antimicrob Agents Chemother. 2007;51:4090–7.
Article
PubMed
CAS
PubMed Central
Google Scholar
Dewi RM. Angka Kegagalan Pengobatan Klorokuin di Daerah dengan Beda Endemisitasnya; Kajian dengan Teknik PCR dan Kovensional. 2002. http://repository.bkpk.kemkes.go.id/1607/
Estiana L. Resistensi fansidar dan klorokuin:: Kajian uji sensitifitas serta faktor-faktor yang berhubungan dengan terjadinya resistensi di Kecamatan Pituruh Kabupaten Purworejo . [Yogyakarta]: Universitas Gadjah Mada; 2000. http://etd.repository.ugm.ac.id/penelitian/detail/5450
Sutanto I, Supriyanto S, Ruckert P, Purnomo, Maguire JD, Bangs MJ. Comparative efficacy of chloroquine and sulfadoxine–pyrimethamine for uncomplicated Plasmodium falciparum malaria and impact on gametocyte carriage rates in the East Nusatenggara province of Indonesia. Am J Trop Med Hyg. 2004;70:467–73.
Arubusman M. Evaluasi hasil guna kombinasi artesunat-amodiakuin dan primakuin pada pengobatan malaria falciparum tanpa komplikasi di Kabupaten Alor Propinsi Nusa Tenggara Timur. [Yogyakarta]: Universitas Gadjah Mada; 2009.
Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 1998;17:3807–15.
Article
PubMed
CAS
PubMed Central
Google Scholar
Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine–pyrimethamine versus sulfadoxine–pyrimethamine alone in Irian Jaya, Indonesia. Am J Trop Med Hyg. 2001;65:309–17.
Article
PubMed
CAS
Google Scholar
Asih PBS, Rozi IE, Dewayanti FK, Wangsamuda S, Zulfah S, Robaha M, et al. Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia. Malar J. 2022;21:95.
Article
PubMed
CAS
PubMed Central
Google Scholar
Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, et al. Chloroquine-resistant Plasmodium vivax: in vitro characterization and association with molecular polymorphisms. PLoS ONE. 2007;2: e1089.
Article
PubMed
PubMed Central
Google Scholar
Ratcliff A, Siswantoro H, Kenangalem E, et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg. 2007;101:351–9.
Poespoprodjo JR, Kenangalem E, Wafom J, Chandrawati F, Puspitasari AM, Ley B, et al. Therapeutic response to dihydroartemisinin–piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia. Am J Trop Med Hyg. 2018;98:677–82.
Fryauff DJ, Soekartono, Tuti S, Leksana B, Suradi, Tandayu S, et al. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. Trans R Soc Trop Med Hyg. 1998;92:82–3.
Murphy GS, Basri H, Purnomo, Andersen Em, Bangs MJ, Pount DL, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 1993;341:96–100.
Kim ES, Na BK, Park Y-K, Chung M-H, Lee J-S, Cheon S-M, et al. A case of chloroquine-resistant Plasmodium vivax malaria imported from Indonesia. Infect Chemother. 2008;40:52–7.
Article
Google Scholar
Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM. Therapeutic efficacies of artesunate–sulfadoxine–pyrimethamine and chloroquine–sulfadoxine–pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob Agents Chemother. 2002;46:3947–53.
Article
PubMed
CAS
PubMed Central
Google Scholar
Salwati E, Handayani S, Jekti RP. Identifikasi single nucleotide polymorphism (SNP) Gen pvmdr1 pada Penderita Malaria Vivaks di Minahasa Tenggara (Sulawesi Utara). J Biotek Medisiana Indones. 2014;3:49–57.
Google Scholar
Tjitra E, Maladi M, Prasetyorini B, Suprianto S, Harun S, Nurhayati N, et al. Efficacy of chloroquine, chloroquine plus sulphadoxine-pyrimethamine, and amodiaquine for treatment of vivax malaria in Bangka island, Indonesia: a randomized trial. Med J Indones. 2008;96–106
Asih PB, Rozi IE, Herdiana, Pratama NR, Hidayato A, Marantina SS, et al. The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia. Malar J. 2012;11:291.
Fryauff DJ, Baird JK, Basri H, Sumawinata I, Purnomo, Richie TL, et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet. 1995;346:1190–3.
Baird JK, Basri H, Subianto B, Fryauff DJ, McElroy PD, Leksana B, et al. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis. 1995;171:1678–82.
Article
PubMed
CAS
Google Scholar
Pasaribu AP, Chokejindachai W, Sirivichayakul C, Tanomsing N, Chavez I, Tjitra E, et al. A randomized comparison of dihydroartemisinin–piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia. J Infect Dis. 2013;208:1906–13.
Article
PubMed
CAS
PubMed Central
Google Scholar
Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, Kysdarmanto. In Vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg. 1997;56:627–31.
Sutanto I, Suprijanto S, Nurhayati, Manoempil P, Baird JK. Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia. Am J Trop Med Hyg. 2009;81:338–42.
Spalding MD, Eyase F, Akala HM, Bedno SA, Progge ST, Coldren RL, et al. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu. Kenya Malar J. 2010;9:338.
Article
PubMed
CAS
Google Scholar
Kublin JG, Dzinjalamala FK, Kamwendo DD, et al. Molecular markers for failure of sulfadoxine–pyrimethamine and chlorproguanil–dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380–8.
Article
PubMed
CAS
Google Scholar
Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether–lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother. 2006;50:1893–5.
Article
PubMed
CAS
PubMed Central
Google Scholar
Rachmad B. Isolasi Dan Identifikasi Mutasi Gen Pfk13 (Pf3d7_1343700) Sebagai Penanda Resistensi Artemisinin Pada Isolat Plasmodium falciparum Asal Lampung. Prosiding dalam rangka Rakernas XIV & Temu Ilmiah XXII. 2019. p. 25–40.
Small-Saunders JL, Hagenah LM, Wicht KJ, Dhingra SK, Deni I, Kim J, et al. Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance. PLoS Pathog. 2022;18: e1010278.
Article
PubMed
CAS
PubMed Central
Google Scholar
Pava Z, Puspitasari AM, Rumaseb A, Handayuni I, Trianty L, Utami R, et al. Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of artemisinin-based combination therapy in Papua, Indonesia. PLoS Negl Trop Dis. 2020;14: e0008295.
Article
PubMed
CAS
PubMed Central
Google Scholar
Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, et al. pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob Agents Chemother. 2003;47:87–94.
Article
PubMed
CAS
PubMed Central
Google Scholar
Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001–8.
Article
PubMed
CAS
PubMed Central
Google Scholar
Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 1990;345:255–8.
Article
PubMed
CAS
Google Scholar
Sá JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, et al. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci USA. 2009;106:18883–9.
Article
PubMed
PubMed Central
Google Scholar
Lederman ER, Maguire JD, Sumawinata IW, Chand K, Elyazar I, Estiana L, et al. Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia. Malar J. 2006;5:108.
Article
PubMed
PubMed Central
Google Scholar
Atroosh WM, Al-Mekhlafi HM, Mahdy MA, Surin J. The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia. Malar J. 2012;11:251.
Article
PubMed
CAS
PubMed Central
Google Scholar
Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403:906–9.
Article
PubMed
CAS
Google Scholar
Roepe PD. Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria. Future Microbiol. 2009;4:441–55.
Article
PubMed
CAS
Google Scholar
Srimuang K, Miotto O, Lim P, Fairhurst RM, Kwiatkowski DP, Woodrow CJ, et al. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration [published correction appears in Malar J. 2018;17:325]. Malar J. 2016;15:541.
Bangs MJ, Tjitra E, Kadir A, Ingkokusumo G, Fryauff DJ, Sumawinata I, et al. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Am J Trop Med Hyg. 1999;60:542–6.
Article
PubMed
Google Scholar
Sidhu ABS, Valderramos SG, Fidock DA. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol. 2005;57:913–26.
Article
PubMed
CAS
Google Scholar
Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnädig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.
Article
PubMed
CAS
PubMed Central
Google Scholar
Calçada C, Silva M, Baptista V, Thathy V, Silva-Pedrosa R, Granja D, et al. Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in Southeast Asia with increased substrate transport. mBio. 2020;11:e02093–20.
Marfurt J, Wirjanata G, Prayoga P, Chalfein F, Leonardo L, Sebayang BF, et al. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia. Int J Parasitol Drugs Drug Resist. 2021;17:46–56.
Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005;94:181–90.
Article
PubMed
CAS
Google Scholar
Achieng AO, Muiruri P, Ingasia LA, Opot BH, Juma DW, Yeda R, et al. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Int J Parasitol Drugs Drug Resist. 2015;5:92–9.
Article
PubMed
PubMed Central
Google Scholar
Baliraine FN, Rosenthal PJ. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis. 2011;204:1120–4.
Article
PubMed
CAS
PubMed Central
Google Scholar
Syafruddin D, Asih PBS, Casey GJ, Maguire J, Baird JK, Nagesha HS, et al. Molecular epidemiology of Plasmodium falciparum resistance to antimalarial drugs in Indonesia. Am J Trop Med Hyg. 2005;72:174–81.
Article
PubMed
Google Scholar
Siswantoro H, Hasugian AR, Avrina R, Risniati Y. Efikasi dan Keamanan Dihidroartemisininpiperakuin (Dhp) pada Penderita Malaria Falsiparum Tanpa Komplikasi di Kalimantan Dan Sulawesi. Media Penelitian dan Pengembangan Kesehatan. 2011;21.
Tatura SNN. Efikasi Obat Kloroquine, Kina, Artesunate-SP, Artesunate-Amodiaquine, Artesunate-Lumafentrin pada Anak Malaria Falciparum di BLU RSUP Prof. Dr RD Kandou Manado Sari Pediatri. 2016;10:417.
Article
Google Scholar
Ali M, Hidayatullah TA, Alimuddin Z, Sabrina Y. Sequence diversity of pfmdr1 and sequence conserve of pldh in Plasmodium falciparum from Indonesia: its implications on designing a novel antimalarial drug with less prone to resistance. Iran J Parasitol. 2013;8:522–9.
PubMed
PubMed Central
Google Scholar
Asih PB, Syafruddin D, Leake J, Sorontou T, Sadikin M, Sauerwein RW, et al. Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, Indonesia. Int J Parasitol Drugs Drug Resist. 2011;1:28–32.
Article
PubMed
CAS
PubMed Central
Google Scholar
Sutanto I, Endawati D, Ling LH, Laihad F, Setiabudy R, Baird JK. Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia. Malar J. 2010;9:52.
Article
PubMed
PubMed Central
Google Scholar
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua. Indonesia PLoS Med. 2008;5: e128.
Article
PubMed
Google Scholar
Brega S, Meslin B, de Monbrison F, Severini C, Gradoni L, Udomsangpetch R, et al. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J Infect Dis. 2005;191:272–7.
Article
PubMed
CAS
Google Scholar
Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, et al. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine–pyrimethamine: mutations in pvdhfr and pvmdr1. J Infect Dis. 2008;198:409–17.
Article
PubMed
Google Scholar
Sibley CH, Hyde JE, Sims PFG, Plowe C v, Kublin JG, Mberu EK, et al. Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 2001;17:582–8.
Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA. 1988;85:9109–13.
Article
PubMed
CAS
PubMed Central
Google Scholar
Cortese JF, Caraballo A, Contreras CE, Plowe C v. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis. 2002;186:999–1006.
Andriantsoanirina V, Durand R, Pradines B, Baret E, Bouchier C, Ratsimbasoa A, et al. In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malar J. 2011;10:283.
Article
PubMed
CAS
PubMed Central
Google Scholar
Sugaram R, Suwannasin K, Kunasol C, Mathema VB, Day NPJ, Sudathip P, et al. Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016. Malar J. 2020;19:107.
Article
PubMed
CAS
PubMed Central
Google Scholar
Nzila-Mounda A, Mberu EK, Sibley CH, Plowe CV, Winstanley PA, Watkins WM. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob Agents Chemother. 1998;42:164–9.
Article
PubMed
CAS
PubMed Central
Google Scholar
Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA. 1988;85:9114–8.
Article
PubMed
CAS
PubMed Central
Google Scholar
Wang P, Lee C-S, Bayoumi R, Djimde A, Doumbo O, Swedberg G, et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol. 1997;89:161–77.
Article
PubMed
CAS
Google Scholar
Rahman HA, Zakaria R, Abdullah MS, Nagappan S, Cox-Singh J, Singh B. Short report: differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. Am J Trop Med Hyg. 2001;64:28–31.
Article
PubMed
Google Scholar
Biswas S, Escalante A, Chaiyaroj S, Angkasekwinai P, Lal AA. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop Med Int Health. 2000;5:737–43.
Article
PubMed
CAS
Google Scholar
Jelinek T, Kilian AH, Kabagambe G, von Sonnenburg F. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes. Am J Trop Med Hyg. 1999;61:463–6.
Article
PubMed
CAS
Google Scholar
Sattabongkot J, Lim CS, Kim T-S, Kim K, Chen J-H, Lin K, et al. Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries. Am J Trop Med Hyg. 2010;83:474–9.
Article
PubMed
PubMed Central
Google Scholar
Leartsakulpanich U, Imwong M, Pukrittayakamee S, White NJ, Snounou G, Sirawaraporn W, et al. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol Biochem Parasitol. 2002;119:63–73.
Article
PubMed
CAS
Google Scholar
Brega S, de Monbrison F, Severini C, Udomsangpetch R, Sutanto I, Ruckert P, et al. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob Agents Chemother. 2004;48:2581–7.
Article
PubMed
CAS
PubMed Central
Google Scholar
Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, et al. Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase. Malar J. 2008;7:72.
Article
PubMed
PubMed Central
Google Scholar
Imwong M, Pukrittayakamee S, Rénia L, Letourneur F, Charlieu J-P, Leartsakulpanich U, et al. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother. 2003;47:1514–21.
Article
PubMed
CAS
PubMed Central
Google Scholar
Hastings MD, Porter KM, Maguire JD, Susanti I, Kania W, Bamgs MJ, et al. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J Infect Dis. 2004;189:744–50.
Article
PubMed
CAS
Google Scholar
Eldin de Pécoulas P, Basco LK, Tahar R, Ouatas T, Mazabraud A. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene. 1998;211:177–85.
Eldin de Pécoulas P, Tahar R, Ouatas T, Mazabraud A, Basco LK. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol. 1998;92:265–73.
Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, et al. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine–pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother. 2001;45:3122–7.
Article
PubMed
CAS
PubMed Central
Google Scholar
Risniati Y, Hasugian AR, Siswantoro H, Avrina R, Tjitra E, Delima. Respon klinis dan parasitologis dihidroartemisinin-piperakuin pada subyek malaria falsiparum dan malaria vivaks pada hari ke-3 kunjungan ulang. Media Litbang Kesehatan. 2011;21:57–165.
Lidia K, Deo DA, Pakan PD, Riwu M. Evaluation of therapeutic efficacy and safety of dihydroartemisinin–piperaquine in uncomplicated Plasmodium falciparum monoinfection in Timor Tengah Selatan District, Nusa Tenggara Timur, Indonesia. Southeast Asian J Trop Med Public Health. 2018;49:733–40.
Google Scholar
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lin P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria [published correction appears in N Engl J Med. 2014;371:786]. N Engl J Med. 2014;371:411–23.
Article
PubMed
PubMed Central
Google Scholar
Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357–65.
Article
PubMed
CAS
PubMed Central
Google Scholar
Hamilton WL, Amato R, van der Pluijm RW, Jacob CG, Quang HH, Thuy-Nhien NT, et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect Dis. 2019;19:943–51.
Article
PubMed
PubMed Central
Google Scholar
Parobek CM, Lin JT, Bailey JA, Lon C, Saunders DL, Juliano JJ, et al. Longitudinal pooled deep sequencing of the Plasmodium vivax K12 Kelch gene in Cambodia reveals a lack of selection by artemisinin. Am J Trop Med Hyg. 2016;95:1409–12.
Article
PubMed
PubMed Central
Google Scholar
Loesbanluechai D, Kotanan N, de Cozar C, Kochakarn T, Ansbro MR, Chotivanich K, et al. Overexpression of plasmepsin II and plasmepsin III does not directly cause a reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine, and piperaquine. Int J Parasitol Drugs Drug Resist. 2019;9:16–22.
Article
PubMed
CAS
Google Scholar
Gresty K, Anderson K, Pasay C, Waters NC, Cheng Q. Polymorphisms in Plasmodium falciparum Kelch 13 and P. vivax Kelch 12 genes in parasites collected from three South Pacific countries prior to extensive exposure to artemisinin combination therapies. Antimicrob Agents Chemother. 2019;63:e00536–19.
Wang M, Siddiqui FA, Fan Q, Luo E, Cao Y, Cui L. Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia. Malar J. 2016;15:537.
Article
PubMed
PubMed Central
Google Scholar
Duanguppama J, Mathema VB, Tripura R, Day NP, Maxay M, Nguon C, et al. Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia. Malar J. 2019;18:114.
Article
PubMed
PubMed Central
Google Scholar
WHO. Global report on antimalarial drug efficacy and drug resistance: 2000–2010. Geneva, World Health Organization. Global Malaria Programme. 2010. https://www.who.int/publications/i/item/9789241500470
Lubis IND, Wijaya H, Lubis M, Lubis CP, Beshir KB, Sutherland CJ. Plasmodium falciparum isolates carrying pfk13 polymorphisms harbor the SVMNT allele of pfcrt in Northwestern Indonesia. Antimicrob Agents Chemother. 2020;64:e02539-e2619.
Article
PubMed
CAS
PubMed Central
Google Scholar
Purworejo Health Report 2019. Available from: http://dinkes.purworejokab.go.id/
Southwest Sumba Health Report 2019. Available from: https://dinkes.sumbabaratkab.go.id/
Kulon Progo Health Report 2016. Available from: https://dinkes.kulonprogokab.go.id/
Gunung Kidul Health Report 2019. Available from: https://gunungkidulkab.go.id/D-7c5c10bd7afb63f86b3f053bd8c45ae7-NR-100-0.html
Wonosobo Health Report 2019. Available from: https://dinkes.wonosobokab.go.id/
Magelang Health Report 2019. Available from: https://dinkes.magelangkab.go.id/
Cilacap Health Report 2019. Available from: https://dinkes.cilacapkab.go.id/
Jepara Health Report 2019. Available from: https://dinkes.jepara.go.id/
Lampung Health Report 2019. Available from: https://dinkes.lampungprov.go.id/
Gorontalo Health Report 2019. Available from: https://dinkes.gorontalokota.go.id/
Makassar district Health Report 2019. Available from: https://makassarkota.go.id/dinas-kesehatan/
Sulawesi Health Report 2019. Available from: https://dinkes.sulselprov.go.id/
Kamelia M, Supargiyono, Wijayanti MA. Study on chloroquine resistance transporter (pfcrt) gene polymorphism of Plasmodium falciparum in malaria patients in Lampung. Trop Med J. 2011;1:1.
Suwandi JF, Asmara W, Kusnanto H, Syafruddin D, Supargiyono S. Efficacy of artemisinin base combination therapy and genetic diversity of Plasmodium falciparum from uncomplicated malaria falciparum patient in district of Pesawaran, Province of Lampung. Indonesia Iran J Parasitol. 2019;14:143–50.
PubMed
Google Scholar
Syafruddin D. Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in 4 sentinel sites in Indonesia. 2016.
Reteng P, Vrisca V, Sukarno I, Djarkoni IH, Jacobs GE, Runtuwene LR, et al. Genetic polymorphisms in Plasmodium falciparum chloroquine resistance genes, pfcrt and pfmdr1, in North Sulawesi, Indonesia. BMC Res Notes. 2017;10:147.
Article
PubMed
PubMed Central
Google Scholar
Lamaka B, Arsin A, Alam G, Ishak H, Hatta M, Phihantono P. Plasmodium falciparum gene polymorphisms Pfmdr1 N86Y and drug self-medication in the endemic areas of West Papua Region, Indonesia. Int J Sci Basic Applied Res. 2017;33:103–11.
Google Scholar
Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, et al. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis. 2008;198:1558–64.
Article
PubMed
CAS
Google Scholar
Asih PB, Marantina SS, Nababan R, et al. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine–pyrimethamine treatment outcomes in Indonesia. Malar J. 2015;14:365.
Article
PubMed
PubMed Central
Google Scholar